---
title: Targeted agents in patients with progressive glioblastoma-A systematic meta-analysis
  of randomized clinical trials
date: '2024-12-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39618405/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241202180341&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The aim of this systematic meta-analysis was to establish
  evidence for the use of targeted therapies in progressive GB. While some studies
  demonstrated benefits for OS and/or PFS, those results have to be interpreted with
  caution as most studies had major methodological weaknesses, including potential
  differences in sample size, trial design, or the initial distribution of prognostic
  ...'
disable_comments: true
---
CONCLUSIONS: The aim of this systematic meta-analysis was to establish evidence for the use of targeted therapies in progressive GB. While some studies demonstrated benefits for OS and/or PFS, those results have to be interpreted with caution as most studies had major methodological weaknesses, including potential differences in sample size, trial design, or the initial distribution of prognostic ...